Outcomes of patients with acute severe autoimmune hepatitis: Predictors of non‐response to corticosteroids and need for liver transplantation
United European Gastroenterology Journal · 2024
DOI: 10.1002/ueg2.12582 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Ahad Eshraghian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Transplant Center, Avicenna Hospital, Shiraz, Iran. Hauptthemen laut MEDLINE: Liver Transplantation, Hepatitis, Autoimmune, International Normalized Ratio, Adrenal Cortex Hormones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Acute severe autoimmune hepatitis (AS‐AIH) is an evolving concept and the outcomes and optimal treatment have been less studied. In this study, we aimed to investigate the outcomes of patients with AS‐AIH and predictors of non‐response to corticosteroid therapy and need for liver transplantation.
Methods
In a retrospective cohort, we included patients with AS‐AIH admitted to our liver center. We defined AS‐AIH based on the international autoimmune hepatitis group score as acute presentation of AIH with an international normalized ratio (INR) ≥ 1.5 and without liver cirrhosis and hepatic encephalopathy. All patients received high dose corticosteroid therapy. Treatment response was defined as liver transplant free survival at 4 months after presentation. Factors associated with response to corticosteroids and survival of patients were studied.
Results
In total, 61 patients with AS‐AIH were included. Forty‐seven patients responded to corticosteroid therapy. In the multivariate regression model, baseline INR (odds ratio [OR]: 0.184; 95% confidence interval [CI]: 0.048–0.699; p = 0.013) and delayed versus early initiation of corticosteroid (after vs. before 5 days of presentation) (OR: 0.189; 95% CI: 0.039–0.919; p = 0.039) were independent predictors of clinical non‐response to corticosteroid therapy. In the multivariable Cox regression model, baseline INR level (hazard ratio [HR]: 2.542; 95% CI: 1.188–5.440; p = 0.016) and delayed initiation of corticosteroids (HR: 3.578; 95% CI: 1.084–11.812; p = 0.036) were independent predictors of liver transplant free survival at 6 months after diagnosis.
Conclusion
Delayed initiation of corticosteroid therapy might be predictive of clinical non‐response to medical therapy and need for liver transplantation in patients with AS‐AIH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shiraz Transplant Center, Avicenna Hospital, Shiraz, Iran.
- Shiraz Transplant Center, Avicenna Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Gastroenterology and Hepatology, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Hepatobiliary Pancreatic and Transplant Surgery, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Ahad Eshraghian, Alireza Taghavi, Saman Nikeghbalian
Zitieren
APA
Eshraghian, A., Taghavi, A., & Nikeghbalian, S. (2024). Outcomes of patients with acute severe autoimmune hepatitis: Predictors of non‐response to corticosteroids and need for liver transplantation. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12582
Vancouver
Eshraghian A, Taghavi A, Nikeghbalian S. Outcomes of patients with acute severe autoimmune hepatitis: Predictors of non‐response to corticosteroids and need for liver transplantation. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12582
BibTeX
@article{Eshraghian2024,
author = {Eshraghian, Ahad and Taghavi, Alireza and Nikeghbalian, Saman},
title = {Outcomes of patients with acute severe autoimmune hepatitis: Predictors of non‐response to corticosteroids and need for liver transplantation},
journal = {United European Gastroenterology Journal},
year = {2024},
doi = {10.1002/ueg2.12582}
}
EUVIMED